With ageing, there is a loss of adult stem cell function. However, there is no direct evidence that this has a causal role in ageing-related decline. We tested this using muscle-derived stem / progenitor cells (MDSPCs) in a murine progeria model. Here we show that MDSPCs from old and progeroid mice are defective in proliferation and multilineage differentiation. Intraperitoneal administration of MDSPCs, isolated from young wild-type mice, to progeroid mice confer signifi cant lifespan and healthspan extension. The transplanted MDSPCs improve degenerative changes and vascularization in tissues where donor cells are not detected, suggesting that their therapeutic effect may be mediated by secreted factor(s). Indeed, young wild-type-MDSPCs rescue proliferation and differentiation defects of aged MDSPCs when co-cultured. These results establish that adult stem / progenitor cell dysfunction contributes to ageing-related degeneration and suggests a therapeutic potential of post-natal stem cells to extend health.
universal characteristic of ageing is the loss of regenerative capacity leading to an impaired ability to respond to stress and, therefore, increased morbidity and mortality 1 . Th is has led to the hypothesis that ageing is caused, in part, by the loss of functional adult stem cells necessary for tissue regeneration 2, 3 . Indeed, mice greater than two years of age have a signifi cant reduction in the number and proliferative capacity of neural stem cells 4, 5 and male germline stem cells 6, 7 . In contrast, with ageing, haematopoietic stem cell (HSC) numbers are preserved but their function is lost 8, 9 . Muscle satellite cells also lose stem cell properties with ageing, but their abundance in old age remains controversial 10 -13 . Ageingrelated changes in bone-marrow-derived mesenchymal stem cells (MSCs) include loss of proliferation and diff erentiation potential, increase in senescence and loss of capacity to form bone in vivo 14, 15 . Similarly, MSCs derived from the bone marrow of patients with Hutchinson -Gilford progeria syndrome, a disease of dramatically accelerated ageing, are defective in their ability to diff erentiate 16 . Adipose-derived multipotent cells show an age-dependent loss of self-renewal capacity and an increased propensity for adipogenesis 17 . Despite this extensive evidence for adult stem cell decline with ageing, it is not known whether old stem cells contribute to ageingrelated degenerative changes or are merely a biomarker of it.
Given that ageing-related degenerative changes are universal in the musculoskeletal system 18 -20 , we investigated the impact of ageing on murine muscle-derived stem / progenitor cells (MDSPCs). MDSPCs are multipotent cells isolated from postnatal skeletal muscle through an established preplate technique 21, 22 . Th ey have a capacity for long-term proliferation, are resistant to oxidative and infl ammatory stress, show multilineage diff erentiation and selfrenew, induce neovascularization, and stimulate regeneration of bone, skeletal and cardiac muscles 21,23 -25 . Th ese cells likely reside in the perivascular niche 26 . Th ese characteristics raise the possibility that the loss of MDSPCs or related perivascular progenitor cells could contribute to sarcopenia, osteoporosis 27, 28 and other degenerative diseases associated with ageing.
Here we examine MDSPC function in natural ageing and a mouse model of a human progeria. XFE progeroid syndrome is caused by mutations in XPF (xeroderma pigmentosum complementation group F) and characterized by dramatically accelerated ageing of the epidermal, haematopoietic, endocrine, hepatobiliary, renal, nervous, musculoskeletal and cardiovascular systems 29 . XPF encodes one subunit of an endonuclease that together with its essential binding partner ERCC1 (excision repair cross complementation group 1) participates in numerous DNA repair mechanisms 30 . XFE progeroid syndrome was modelled in the mouse by mutation of the mErcc1 locus to titrate expression of ERCC1 -XPF 31, 32 . Ercc1 − / − mice with undetectable levels of ERCC1 -XPF have a severely reduced lifespan of 1 month (mth) 29, 30, 32 while Ercc1 − / Δ mice, expressing 10 % of the normal level of ERCC1 -XPF have a lifespan of 7 mths (refs 30, 32) . Both strains faithfully mimic the systemic accelerated ageing of XFE progeroid syndrome and demonstrate a highly signifi cant correlation with naturally aged mice at the level of histopathology, pathophysiology and genome-wide transcriptional reprogramming 30, 32, 33, 34 . Our results indicate that MDSPC function is adversely aff ected with accelerated and natural ageing. Th is dysfunction directly contributes to ageing-related degenerative changes since transplantation of functional MDSPCs was suffi cient to extend healthspan and lifespan of progeroid mice. Furthermore, we provide evidence that the therapeutic eff ect of MDSPCs may be mediated by secreted factors that act systemically.
Results
Loss of stemness properties with ageing . MDSPCs are slowly adhering cells isolated from skeletal muscle and enriched through a preplate technique 21, 22 . Previously, we reported isolating these multipotent cells from young (3-week (wk)-old) mice 22, 35 . To determine whether MDSPCs could also be isolated from adult and old mice, we followed the same preplate technique, and the resulting cells were analysed for expression of stem / progenitor cell markers (CD34, Sca-1). Cells isolated from skeletal muscle of young (3-wks), adult (19-wks) , and old wild-type (WT) (2-years (yrs)) mice through this technique expressed CD34 and Sca-1 ( Fig. 1a ) , establishing that MDSPCs could be isolated from mice of all ages. Although expression of CD34 appeared mildly attenuated in the older cell populations, Sca-1, which is a more stable marker of MDSPCs 36 , was similarly expressed in all three populations. Furthermore, MDSPCs isolated from adult WT mice showed multilineage diff erentiation ( Fig. 1b ) .
To determine whether there is a loss of stem cell function with ageing and progeria, MDSPCs were isolated from old WT mice (2-yrs) as well as progeroid Ercc1 − / − (2 -3-wks) and Ercc1 − / Δ (5-mths) mice and their proliferation and diff erentiation kinetics measured in vitro . As controls, MDSPCs were isolated from age-matched WT littermates of the progeroid mice and Xpa − / − (xeroderma pigmentosum complementation group A) mice (3-wks), which are defective in nucleotide excision repair of DNA like ERCC1-deficient mice, but do not age rapidly 37 . To measure proliferation of MDSPCs, an equivalent number of cells from each population were plated, and live-cell imaging (LCI) 38 was used to measure growth kinetics ( Fig. 1c ) . Analysis of images captured from the diff erent cell populations revealed that proliferation of MDSPCs isolated from the old WT, Ercc1 − / − and Ercc1 − / Δ mice, but not Xpa − / − mice, was signifi cantly reduced relative to MDSPCs isolated from young WT mice ( * P < 0.05, Tukey ' s test). Th e average population-doubling time (PDT) was prolonged in MDSPCs isolated from old mice [18 hours (h)] and progeroid mice (20 -27 h) compared with young WT mice (15 h) ( Fig. 1c ) . In support of this, the division time (DT) of single cells tracked within the population, or analysed as isolated clones, was also prolonged for old WT-MDSPCs and ERCC1-defi cient MDSPCs compared with young WT-MDSPCs ( Supplementary Table S1 ). Th ese data demonstrate that the proliferation capacity of MDSPCs diminishes with age.
To determine whether the capacity for myogenic diff erentiation is aff ected in old and progeroid MDSPCs, the cells were cultured to confl uence and switched to diff erentiation medium (low serum). Th e young WT-and Xpa − / − MDSPCs fused to form multinucleated myotubes expressing fast myosin heavy chain (f-MyHC), a marker of terminal myogenic diff erentiation ( Fig. 1d ) . In contrast, MDSPCs isolated from old WT and progeroid ERCC1-defi cient mice formed signifi cantly fewer and smaller myotubes indicating impaired diff erentiation ( Fig. 1d ; * P < 0.001; Kruskal -Wallis ANOVA on ranks). Th e diff erentiation defect was confi rmed by measuring the expression of myogenic diff erentiation markers MyHC, desmin, and myogenin ( Fig. 1e ) . Myogenic diff erentiation of individual MDSPC clones from old and progeroid mice was also signifi cantly reduced, compared with young WT mice ( Supplementary Fig. S1 ; * P < 0.001, Kruskal -Wallis ANOVA on ranks). Similarly, osteogenic and chondrogenic diff erentiation of progeroid and old MDSPCs was attenuated compared with cells isolated from young WT mice ( Fig. 1b ) . In contrast, the capacity for adipogenic diff erentiation was retained in aged MDSPCs. To determine whether the myogenic diff erentiation defect translated in vivo , MDSPCs isolated from progeroid mice were injected intramuscularly (IM) into mdx mice, a model of Duchenne ' s muscular dystrophy 39 . Indeed, cells derived from Ercc1 − / Δ mice had an impaired ability to regenerate muscle fi bres in dystrophic muscle compared with young WT-MDSPCs ( Fig. 1f,g ; P < 0.001, Mann -Whitney rank sum test). Cumulatively, these data provide evidence of a signifi cant loss of stemness properties, including proliferation under clonogenic conditions, multipotential diff erentiation and tissue regeneration, in MDSPC populations isolated from old and progeroid mice.
To rule out the possibility that the stem cell dysfunction was an artefact caused by extensive passaging of MDSPCs ex vivo , we measured the number of cells with stem / progenitor surface markers and capacity for myogenic diff erentiation at the earliest possible time point following isolation from skeletal muscle. Preplate 1 and 2 (pp1 -2; Fig. 2a ), which constitute all cells directly isolated from skeletal muscle, were induced to diff erentiate within 24 h of isolation. f-MyHC positive myotube formation was impaired in cells isolated from the skeletal muscle of progeroid ERCC1-defi cient mice compared with WT littermates ( Fig. 2b ) . Similarly, expression of a second terminal myogenic diff erentiation marker, myogenin, was reduced in the ERCC1-defi cient cells compared with WT controls ( Fig. 2c ) . Twenty-four-hours post-isolation from skeletal muscle, those cells that remained nonadherent were stained for surface markers Sca-1, CD34 and CD45 and analysed by fl uorescenceactivated cell sorting (FACS) to quantify the mixed population of non-haematopoietic stem / progenitor cells in the muscle ( Fig. 2d ) . Sca-1 is expressed on adult stem cells, a sub-population of myoblasts 40 , muscle-derived fi brogenic / adipogenic progenitors 41 , and a non-myogenic population of cells that emerge in muscle with ageing 42 .
In young WT mice, ~ 20 % of the cells were Sca-1 + / CD34 + / CD45 − . In contrast, < 10 % of the cells isolated from old or progeroid skeletal muscle were Sca-1 + / CD34 + / CD45 − . Averaging To determine whether there is a diff erence in the function of muscle stem cells between aged and young organisms in vivo , we examined muscle regeneration utilizing a well-established cardiotoxin injury-induced model ( Supplementary Methods ) 43 . Th e total area of muscle regeneration, as defi ned by centronucleated fi bres, did not signifi cantly diff er between young WT, old WT, and progeroid mice ( Supplementary Table S2 ). However, there was a dramatic diff erence in the average cross-sectional area of the regenerated myofi bres in old and progeroid mice compared with young adult mice ( Fig. 3a ) . More than 50 % of the centronucleated, dystrophin-positive myofi bres in old and progeroid mice had an area of ≤ 500 μ m 2 ( Fig. 3b ) . In contrast, > 60 % of the myofi bres in young WT mice had an area of > 1,000 μ m 2 , indicative of signifi cantly more mature regenerated myofi bres ( P < 0.001; Kruskal -Wallis ANOVA on ranks ( Fig. 4a ) . Similarly, MDSPCs isolated from old WT or progeroid Ercc1 − / − mice did not have a signifi cant impact on lifespan. Th e young WT-MDSPCs were also injected IP into Ercc1 − / Δ mice at 6 -7 wks of age and again 6 wks later. Th e age at onset of characteristic progeroid symptoms was measured biweekly, including dystonia, trembling, kyphosis, ataxia, muscle wasting, loss of vision, urinary incontinence and decreased spontaneous activity. Th e results were compared with littermate Ercc1 − / Δ mice treated with vehicle only in a pairwise fashion. Th e investigators were blinded to the treatment arm. Th e ageing score, representing the fraction of symptoms that were delayed in mutant mice treated with MDSPCs compared with a mutant littermate treated with PBS, revealed a highly signifi cant diff erence between treatment groups ( Fig. 4b ; * * * P < 0.0008; Student ' s t -test). Th ese data provide evidence that loss of stem cell function has a direct causal role in ageingrelated degeneration.
Young WT-MDSPCs engraft aft er transplantation . To address the question of how MDSPCs could extend healthspan and lifespan, we asked whether the donor cells engraft ed in host tissues. Young WT-MDSPCs, transduced with a retroviral vector containing LacZ with a nuclear localization sequence ( nLacZ ), were injected IP into Ercc1 − / − mice ( n = 8). Fourteen tissues were analysed ( Supplementary Table S4 ) for the presence of donor cells. LacZ + cells were detected in the parenchyma of the liver and kidney, as well as connective tissues associated with pancreas and spleen of all mice analysed ( Fig. 5 ) . Similar results were obtained in animals euthanized from 1 to 9 wks post-injection. LacZ + cells were also detected in lung, oesophagus, thymus, bladder / ureter, spinal cord, and bone marrow of at least one mouse ( Fig. 5 ; Supplementary  Fig. S2 ). Importantly, donor cells were not detected in the heart, brain, skeletal muscles, and lymph nodes of any mice. Th e extent of donor cell engraft ment and expansion is limited, indicating that the benefi cial eff ects of MDSPCs is not due to tissue reconstitution Young WT-MDSPCs restore the function of aged MDSPCs . In a progeria model ( Ercc1 − / − mice), young WT-MDSPCs had a therapeutic eff ect. However, the duration of the experiment ( < 3 wks) and the limited extent of engraft ment of IP-injected MDSPCs, as far as we could detect, made it unlikely that this positive eff ect was a result of substantial MDSPC engraft ment, proliferation, diff erentiation and tissue regeneration. Th us, we next asked whether young WT-MDSPCs confer their therapeutic eff ects through a paracrine mechanism, requiring secreted factors. MDSPCs isolated from 14-day-old progeroid Ercc1 − / − mice were co-cultured with the young WT-MDSPCs, using a transwell system ( Fig. 6a ) . Th e proliferation of Ercc1 − / − MDSPCs was measured for 72 h while the cells were exposed to proliferation media from young WT-MDSPCs. Subsequently, the Ercc1 − / − MDSPCs were switched to low-serum media to measure myogenic diff erentiation. Th e proliferation defect of Ercc1 − / − MDSPCs was signifi cantly improved by coculture of the cells with young WT-MDSPCs ( Fig. 6b ; * P < 0.001, Mann -Whitney rank sum test). In addition, myogenic diff erentiation of Ercc1 − / − MDSPCs was improved aft er co-culture with young WT-MDSPCs ( Fig. 6c ) . Likewise, impaired diff erentiation of old WT-MDSPCs was rescued by conditioned media from young WT-MDSPCs. To quantify the improvement, MDSPCs from progeroid Ercc1 − / − or old WT mice were grown in the presence of conditioned media from young WT-MDSPCs, then collected for immunodetection of the terminal myogenic diff erentiation marker f-MyHC ( Fig. 6d ) . f-MyHC expression was dramatically increased (2.5 -9 × ) if the cells were grown in the presence of media from young WT-MDSPCs compared with diff erentiation media alone. Th us young WT-MDSPCs were able to rescue, at least in part, the function (proliferation and diff erentiation) of MDSPCs isolated from progeroid and old mice via secreted factors.
MDSPCs promote neovascularization and tissue regeneration .
To determine whether secreted factors were indeed important for the therapeutic eff ect of MDSPCs, we asked whether there was evidence of improved histopathology in tissues of treated ERCC1-defi cient mice in which transplanted MDSPCs were not detected, in particular, skeletal muscle and brain. We previously demonstrated that the regenerative potential of MDSPCs transplanted into skeletal muscle, heart and bone correlates with their ability to induce angiogenesis 21, 24, 25, 35, 44 . Th us, we asked whether IP injection of young WT-MDSPCs had an eff ect on the vasculature of the brain, as well as muscle fi bre size. Muscle sections were stained for dystrophin to highlight muscle fi bre perimeter and CD31 to identify endothelial cells within microvessels ( Fig. 7a ) . For each image, the total number of muscle fi bres and CD31 + cells were quantifi ed, and the ratio ( # of CD31 + cells / # of muscle fi bres) determined. Muscles of 15-day-old Ercc1 − / − mice had signifi cantly reduced numbers of CD31 + cells at the periphery of muscle fi bres compared with WT littermates ( Fig. 7b ; 0.56 CD31 + cells per fi bre versus 1.25 for WT mice; * P < 0.001, Student ' s t -test). Th e average muscle-fi bre size was also signifi cantly reduced in the Ercc1 − / − mice (324 μ m 2 ) compared with WT littermates ( Fig. 7b ; 734 μ m 2 , * P = 0.002, Mann -Whitney rank sum test). IP injection of young WT-MDSPCs into Ercc1 − / − mice led to a signifi cant increase in the number of CD31 + cells 9 wks postinjection compared with untreated Ercc1 − / − mice that only live 3 -4 wks ( Fig. 7b ; 1 .05 CD31 + vessels / fi bre; § P < 0.05, Tukey ' s test). Similarly, muscle-fi bre size signifi cantly increased ( Fig. 7b ; 1,580 μ m 2 cross-sectional area; § P < 0.05, Dunn ' s test). It is impossible to directly compare the fi bre size between Ercc1 − / − mice transplanted with young WT-MDSPCs to untreated mutant animals of the same age because the latter don ' t live to 9 wks of age ( Fig. 4a ) . Nevertheless, muscle regeneration and growth was evident in Ercc1 − / − mice treated with MDSPCs.
Progeroid Ercc1 − / − mice show reduced vascularization in the brain compared with WT littermates at 3 wks of age ( The ageing score is calculated as the fraction of symptoms that were delayed in a single Ercc1 − / Δ mice injected with young WT-MDSPCs compared with an age-and sex-matched mouse (usually a littermate) injected with PBS ( Supplementary Methods ). The black bars denote the average ageing score for each group ( * * * P < 0.0008, Student ' s t -test).
vasculature was 1.2 % . In Ercc1 − / − mice injected with MDSPCs, vascularization increased approximately to the levels in 3-wk-old WT mice (2.2 versus 2.5 % , respectively) and the improvement was sustained. Ercc1 − / − mice treated with MDSPCs that survived to 9 wks of age, had a vascular area indistinguishable from age-matched WT mice (3.2 versus 3.1 % , P < 0.05, Dunn ' s test). Th ese data demonstrate that there is improvement in the histopathology of several tissues in which donor cell engraft ment was not detected, suggesting that MDSPCs exert their therapeutic eff ect through secreted factors. Using IM injection of nLacZ -labelled MDSPCs to localize donor-cell engraft ment, we analysed host muscle for presence of LacZ + myofi bres and endothelial cells ( Fig. 8 ) . Like IP, IM administration of young WT-MDSPCs into Ercc1 − / − mice ( Fig. 8a , n = 3 mice per group) led to a signifi cant increase in the number of CD31 + cells ( Fig. 8b ; 1 .06 CD31 + vessels per fi bre; § P < 0.05, Tukey ' s test) compared with the non-injected Ercc1 − / − mice (0.56 CD31 + vessels / fi bre). Th e muscle-fi bre cross-sectional area was also signifi cantly increased ( Fig. 8b ; 522 versus 324 μ m 2 , § P < 0.05, Dunn ' s test). At the site of injection, numerous myofi bres with central or peripheral LacZ + nuclei were identifi ed, demonstrating that transplanted MDSPCs have the capacity to integrate into regenerated muscle fi bres ( Fig. 8c ) . In addition, analysis of sections of the gastrocnemius distant from the injection site revealed a shift in the distribution of myofi bre size towards larger regenerating fi bres compared with contralateral non-injected muscle ( Fig. 8d ; P < 0.001, Mann -Whitney rank sum test at 151 -300 and 301 -450). Th is suggests that IM injection of MDSPCs also aff ected host myofibres through a paracrine mechanism, requiring secreted factors. Sections were also stained with X-gal and for CD31 to determine whether donor cells co-localize with CD31 + cells ( Fig. 8e ) . Background staining in Ercc1 − / − mice was extensive, compared with mdx / SCID mice, likely due to interstitial fi brosis. In both cases, there was a lack of co-localization of LacZ and CD31 staining. Th ese data are consistent with our previous fi ndings 25, 45 and the conclusion that transplanted MDSPCs do not directly contribute to blood vessels and thus likely drive host angiogenesis through secreted factors.
Discussion
MDSPCs are stem / progenitor cells isolated from skeletal muscle, a tissue that universally declines in mass and function with ageing 20 . Th is cell population cannot be discriminated from less multipotent progenitors strictly based on surface markers, and thus are diffi cult to quantify. Nevertheless, MDSPCs were isolated from old WT mice and mice with accelerated ageing, using a well-established preplate technique 21, 22 . In both cases, cell proliferation and multilineage differentiation is signifi cantly impaired relative to MDSPCs isolated from young WT mice ( Fig. 1 ) . Furthermore, fewer cells expressing stem / progenitor cell markers are isolated from skeletal muscles of aged and progeroid mice ( Fig. 2 ) . Finally, muscle from aged and progeroid mice has signifi cantly reduced regenerative capacity following injury ( Fig. 3 ; Supplementary Table S2 ) , consistent with previous reports 11 . Th ese data establish that the function of MDSPCs is compromised with ageing, similar to neuronal, mesenchymal, haematopoietic, satellite, and adipose stem cells 4,15,17,46 -48 . Th e similarity of defi cits in MDSPCs from old WT and progeroid mice extends the commonalities between accelerated ageing caused by a defect in DNA repair and natural ageing. Similar parallels were found between Hutchinson-Gilford progeria syndrome and ageing in the MSC compartment 49 . Numerous studies provide evidence that the number and / or function of diverse adult stem cell populations decline with ageing 4, 6, 7, 15, 47, 50, 51 . However, these are largely correlative studies that do not discriminate whether changes in the stem cell compartment have a causative role in ageing or are merely a consequence of ageing. Genetic studies revealed proteins and pathways essential for the maintenance of stem cell function. Mutation of these genes leads to foreshortened lifespan and early onset of some ageingrelated pathologies. For example, mice defi cient in the polycomb protein BMI-1 have a short lifespan 52 , along with defects in selfrenewal of HSCs, leading to adult stem cell depletion 53 . Similarly, mice defi cient in HMGA2 show reduced stem cell numbers and function (self-renewal) throughout the central and peripheral nervous systems 54 . Finally, HSC function and regenerative capacity are signifi cantly diminished in mice harbouring mutations in diverse DNA repair genes or telomerase ( Lig4 Y288C , Ku80 − / − , Xpd TTD , and mTR − / − ) indicating that genome and telomere maintenance are crucial for stem cell function 55, 56 . However, there is no evidence that loss of stem cell function is directly responsible for decreased lifespan and ageing-related pathology in these models. Here we demonstrate that transplantation of functional WT stem / progenitor cells isolated from juvenile mice into hosts harbouring dysfunctional MDSPCs leads to a signifi cant extension of healthspan and lifespan ( Fig. 4 ) . Th ese results provide experimental evidence that the loss of adult stem cell function directly contributes to ageingrelated phenotypes.
Interestingly, the function of MDSPCs from aged mice could be restored if they were co-cultured with young WT-MDSPCs ( Fig. 6 ) . Similar results were seen in vivo using parabiosis 47 . Th ese obser- MDSPCs were plated in the lower compartment of the transwell system in proliferation media. WT-MDSPCs were seeded onto the upper transwell membrane inserts, at the same density, and in the same media. These co-cultures were placed in the LCI system for 72 h to acquire time-lapsed images to measure proliferation of the MDSPCs. As a control, each plate contained wells of Ercc1 − / − MDSPCs without transwell membrane inserts. ( b ) Plotted is the average cell number at each time point calculated from the analysis of three independent populations of Ercc1 − / − MDSPCs co-cultured with young WT-MDSPCs (black line), or without (red line) ± s.d. * P < 0.001, Mann -Whitney rank sum test. ( c ) The transwell inserts were removed after 72 h and the proliferation media was switched to differentiation media. After 2 -3 days, myogenic differentiation of Ercc1 − / − and old WT-MDSPC was tested by immunostaining the cells for f-MyHC (red). Shown are representative images. The nuclear counterstain is DAPI (blue). Scale bar = 100 μ m. ( d ) Quantifi cation of myogenic differentiation of old WT-MDSPCs after growth in media conditioned from young WT-MDSPCs. Young WT-MDSPCs were cultured for 2 days in proliferation media in collagen-coated fl asks, then treated with differentiation media for 3 days. The supernatant from these cultures was collected for use as conditioned media. MDSPCs from 21-day-old progeroid Ercc1 − / − mice and 2-yr-old WT mice were grown in the presence of this conditioned media or unconditioned differentiation media to determine the impact on myogenic differentiation as measured by immunoblot detection of f-MyHC. Densitometric quantifi cation of f-MyHC corrected for β -Actin is indicated below each lane.
vations demonstrate that old, dysfunctional MDSPCs can be rescued by exogenous factors, rather than the cells being inherently defective. Th is is in contrast to aged haematopoietic stem cells, which appear to have an intrinsic defect (reviewed in ref. 57) .
IP administration of young WT-MDSPCs to progeroid mice promoted growth of the animals, decreased skeletal muscle atrophy, and stimulated neovascularization in the brain and muscle, despite the fact that donor cells were not detected in these tissues ( Figs 4 and 7 ) . In addition, transplantation of young WT-MDSPCs directly into progeroid muscle led to muscle regeneration as well as host neovascularization, demonstrating a paracrine mechanism requiring secreted factors ( Fig. 8 ) . Th ese observations suggest that the mechanism by which MDSPCs promote healthspan and lifespan extension is likely through the secretion of stimulatory factor(s) that promote regeneration and that cells from old hosts lose this secretory phenotype. Th is stimulatory factor may be necessary to overcome systemic 48 or local 58 negative regulators of tissue regeneration in aged hosts. Identifi cation of these secreted factors and methods to rejuvenate adult stem cells ex vivo will be critical for regenerative medicine.
Our data demonstrate that transplanted MDSPCs can have systemic eff ects, leading to tissue regeneration in multiple organ systems. Th erefore, MDSPCs may have therapeutic value for delaying ageing-related functional decline and treating human progerias. It will be of critical importance to test other adult stem cell types for a similar therapeutic eff ect.
Methods
Isolation of MDSPCs . All animal experiments were performed with the approval of the University of Pittsburgh Institutional Animal Care and Use Committee. Th e fraction of slow-adhering cells referred to as MDSPCs were isolated from the skeletal muscle of mice via a modifi ed preplate technique 21, 22 . Briefl y, mouse skeletal muscle is enzymatically digested to a single-cell suspension and the cells are separated by their ability to adhere to collagen-coated fl asks. Th e cells that adhere 2 h post-plating are defi ned as preplate 1 (pp1, Fig. 2 ) . Th e non-adherent cells (pp2) are transferred to a fresh fl ask aft er 24 h. Th is is repeated fi ve times to isolate the slowly adhering, stem-cell-enriched MDSPC population (pp6 labelled ft ). MDSPCs were isolated from young WT (14 -21-day-old; f1 C57BL / 6:FVB / n or C57BL / 10J), adult WT (19-wk-old; f1), old WT (2-yr-old; f1), progeroid Ercc1 − / − (14 -21-dayold; f1), Ercc1 − / Δ (19-wk-old; f1) and DNA-repair-defi cient Xpa − / − (21-day-old; C57BL / 6) mice ( n = 3 -4 per strain), which were bred at the University of Pittsburgh Division of Laboratory Animal Research. MDSPCs were cultured in proliferation medium (PM): DMEM supplemented with 10 % horse serum , 10 % fetal bovine serum (FBS) , 1 % penicillin -streptomycin (all from Invitrogen), and 0.5 % chick embryo extract ( Accurate Chemical ), on collagen-type I-coated fl asks. Primary MEFs used for transplantation were prepared from E13 -15 day-old embryos and cultured at 3 % O 2 (ref. 32) .
To isolate individual clones, 5 × 10 5 MDSPCs were resuspended in 500 μ l media and the FACS Aria cytometer ( Becton-Dickinson ) was used to place one MDSPC per well in a 96-well collagen-I-coated plate containing 100 μ l PM medium. Each well was manually checked to confi rm the presence of a single cell. Cells were cultured at 37 ° C, 5 % CO 2 , in a humidifi ed incubator and medium was changed every 2 days.
Proliferation in vitro . Cells were plated at a density of 2,000 cells per well in a collagen-type-I -coated 12-well plate. An imaging system ( Automated Cell Technologies ) equipped with a × 20 objective was used to acquire images at 10-min intervals over a period of 72 h. Forty images at each time point were randomly selected and analysed from three independent experiments on three-to-four distinct cell lines. To estimate PDT, the experimental data sets for each population were curve-fi t to the re-arranged Sherley model 38, 59 , using nonlinear regression to determine the correlation coeffi cient and dividing fraction for each cell genotype.
Th e division time (DT) of individual cells within the population or of isolated clones was measured by determining the time between cytokinesis events using time-lapsed video recordings (72 h in duration). At least 30 cells were tracked over time in at least 3 MDSPC populations per genotype. For clonal experiments, cells were analysed within 5 days aft er isolation of clones from pp6. Th ree-to-four clones were isolated from 2 -3 MDSPC populations of each genotype. DT was, therefore, calculated from 6 -12 clones per genotype ( Supplementary Table S1 ).
Differentiation in vitro . To induce myogenic diff erentiation, MDSPCs were plated at high confl uence in PM for 2 -3 days then shift ed to diff erentiation medium (DM: DMEM, 2 % FBS, 1 % penicillin -streptomycin). Aft er 2 -3 days, immunostaining for f-MyHC, a marker of terminal myogenic diff erentiation, was performed. Aft er cold methanol fi xation, cells were blocked with 5 % goat serum and incubated with f-MyHC mouse monoclonal antibody (1:250; Sigma-Aldrich ), secondary biotinylated IgG (1:250; Vector Laboratories ) for 1 h, and streptavidin-594 (1:500; Sigma-Aldrich ) for 15 min to fl uorescently label the myotubes. To visualize the nuclei, the cultures were then incubated with DAPI (4 ′ , 6 ′ diamidino-2-phyenylindole, 100 ng ml − 1 ; Sigma-Aldrich ) for 10 min. For negative controls, the primary antibody was omitted or replaced with mouse or rabbit IgG. Fluorescent images were captured and processed using a Leica DMIRB microscope equipped with a QImaging Retiga digital camera both using Northern Eclipse soft ware ( v. 6.0 ; Empix Imaging ). We quantifi ed the cells in at least 15 fi elds each from 3 replica platings of 4 independent experiments. Myogenic diff erentiation was calculated as the percent of cells (the number of nuclei, detected by DAPI stain) expressing f-MyHC. For adipogenic, osteogenic, and chondrogenic diff erentiation, MDSPCs were seeded onto 6-well plates and lineage-specifi c diff erentiation media ( Lonza ) was added for 7 days. Expression of lineage-specifi c markers was measured by reverse transcriptase PCR (rtPCR) as described in Supplementary Methods and Supplementary Table S5 . were injected IM with WT-MDSPCs expressing nuclear LacZ to determine whether donor cells integrate into muscle fi bres and contribute to blood vessels. Five days later, the mice were euthanized and the gastrocnemius muscles were isolated for analysis. Muscle sections at the injection site were stained with X-gal, to detect donor cells, and eosin. Scale bar = 50 μ m. ( d ) Histogram of the cross-sectional area distribution of myofi bres in the treated gastrocnemius muscles (black bars) compared the contralateral non-injected muscle (white bars). Data were collected from 6,000 fi bres from multiple sections of four mice per group. The distribution of fi bre size is indicated on the x -axis, representing increasingly more mature fi bres with increased size ( P < 0.001, MannWhitney rank sum test at 151 -300 and 301 -450). ( e ) Sections from the injected muscles stained for CD31 to identify blood vessels (dark brown) and X-gal to identify donor cells (blue). Red arrowheads indicate CD31 + capillary structures. Sections from dystrophic ( mdx / SCID) mice treated the same way are included as a positive control (right panels). Scale bars = 50 μ m.
FACS . Th e preplate technique was utilized to obtain cells from skeletal muscle 21 . Red blood cells were eliminated using a lysis buff er before plating. Aft er 24 h, nonadherent cells in pp3 were collected, centrifuged, resuspended in mouse serum (1:10; Sigma-Aldrich ) on ice and counted. Cells were then labelled with rat monoclonal antibodies against CD34, Sca-1, and CD45 conjugated to FITC, PE (both from BD Pharmingen ), and APC, respectively ( Invitrogen ). A separate fraction of each cell pellet was stained with equivalent volumes of isotype control antibodies. Before analysis, 7-amino-actinomycin D (7-AAD) was added for exclusion of nonviable cells. Cells were analysed on a FACSAria cytometer using FACS Diva soft ware , ( Becton Dickinson ). Sorted gates were defi ned based on separate cell portions that were labelled with equivalent amounts of appropriately conjugated isotype-matched control antibodies. Positive and negative gates were set by analysing isotype or unstained control samples in each analysis. Th e average percent of Sca-1 + / CD34 + / CD45 − cells was normalized to pellet weight. To compare diff erentiation potential, an equal number of sorted cells from each group were plated in 48-well plates and diff erentiation was induced as described above.
Co-culture experiments . Ercc1 − / − MDSPCs were plated in the lower compartment of Transwell Permeable Supports ( Costar ) in PM media at a density of 3,000 cells per well. WT-MDSPCs were seeded into 6.5 mm transwell membrane inserts at the same density in PM media and placed above the ERCC1-defi cient MDSPCs. Th e 24-well plates containing the transwells were then placed in the LCI system for 72 h to acquire time-lapsed images to measure proliferation of the MDSPCs, as described above. As a control, each plate contained wells of Ercc1 − / − MDSPCs without transwell membrane inserts. To measure the diff erentiation potential of Ercc1 − / − MDSPCs aft er co-culture, transwell inserts were removed aft er 72 h and the PM media was switched to DM. Aft er 2 -3 days, myogenic differentiation of the cells was tested by immunostaining for f-MyHC, as described above. To quantify diff erentiation, it was necessary to switch from transwell to conditioned media from young WT-MDSPCs to generate suffi cient cells for quantitative immunodetection of myogenic diff erentiation markers. Young WTMDSPCs were cultured for 2 days in 25 cm 2 collagen-coated fl asks and then treated with diff erentiation media (DMEM medium supplemented with 2 % FBS) for 3 days. Th e supernatant was collected and used as conditioned media. MDSPCs from 21-day-old Ercc1 − / − mice and 2-yr-old WT mice were grown in the presence of this conditioned media or unconditioned diff erentiation media to determine the impact on myogenic diff erentiation.
Western blot . Th ree-to-four days aft er induction of myogenic diff erentiation, cells were lysed in Laemmli Sample Buff er ( Bio-Rad ), boiled for 5 min, and centrifuged at 4,000 r.p.m. for 5 min. Each sample was loaded on a 6 % SDS-polyacrylamide gel, which was run for 2 h by 100 volts and then transferred for 45 min by 20 volts in a semi-dry transferring apparatus. Th e membrane was blocked with 5 % nonfat dry milk ( Bio-rad ) in Tris-buff ered saline Tween-20 for 1 h and then incubated with mouse anti-MyHC (fast) monoclonal antibody (1:500, Sigma-Aldrich ) and mouse anti-β -Actin monoclonal antibody (1:8,000, Sigma-Aldrich ), respectively, overnight at 4 ° C. Aft er washing 3 times with Tris-buff ered saline Tween-20, the membrane was incubated with rabbit anti-mouse IgG (H + L) (1:5,000, Pierce ) for 1 h at room temperature. Blots were developed by ECL solution ( Pierce ). Diff erences in expression were measured by densitometry using soft ware from SCION Corporation (provided by National Institutes of Health) and reported relative to β -Actin.
Tissue staining . Microvascular density was measured by co-staining for dystrophin to highlight muscle fi bres and CD31 to identify endothelial cells present within microvessels 35 . Briefl y, sections of frozen gastrocnemius muscle were formalin fi xed, blocked with serum, and incubated with primary antibodies including CD31 (1:250; BD Biosciences ) and dystrophin (1:300, Abcam ) for 1 h. Goat anti-rat IgG Alexa Fluor 594 (1:300, Invitrogen ) and donkey anti-rabbit Alexa Fluor 488 (1:300, Invitrogen ) were used to detect CD31 and dystrophin, respectively. DAPI was used to identify cell nuclei. For each image, the total number of muscle fi bres and CD31 + cells were counted, and the ratio of CD31 + cells to muscle fi bres was reported 35 . To detect nLacZ expression, tissue sections were fi xed in 1 % glutaraldehyde and incubated with 5-bromo-4-chloro-3-indolyl β -d-galactopyranoside (X-gal) solution for 3 h at 37 ° C and counterstained with haematoxylin and / or eosin. For details on co-localizing CD31 and nLacZ staining, see Supplementary Methods .
Statistics . Statistical analyses were carried out using SigmaStat ( Jandel Scientifi c v2.0 ) soft ware package. Th e paired Student ' s t -test or Mann -Whitney rank sum test was used for direct comparisons between treatment and control groups. For multiple comparisons, the one-way ANOVA or the Kruskal -Wallis one-way ANOVA on ranks was applied. Pairwise multiple comparisons were performed using the Tukey ' s Test or Dunn ' s Method following rank-based ANOVA. All values are expressed as the mean ± s.d. (or s.e.m. where noted), and P < 0.05 was considered signifi cant.
